Jefferies Financial Group’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.05M	Buy	276,887 +255,455	+1,192%	+$2.82M	0.03%	302
2025 Q1	$191K	Buy	+21,432	New	+$191K	﹤0.01%	1162
2023 Q4	–	Sell	-302,130	Closed	-$2.61M	–	1455
2023 Q3	$2.61M	Buy	302,130 +2,130	+0.7%	+$18.4K	0.02%	319
2023 Q2	$3.11M	Buy	+300,000	New	+$3.11M	0.03%	300